NexCAR19, the world’s first humanised CAR-T therapy developed in India, has made gene therapies affordable and accessible ...

Prime Minister Narendra Modi gifted three path-breaking innovations, including CART-T Cell Therapy, India''s first indigemous cancer cell therapy developed by Indian Innovators with the support of the ...

OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces it has been recognised as a Champion in the ‘Cell & Gene Therapy’ category at the 2025 CDMO Leadership ...

In this GEN webinar, LV expert Brianna Jayanthi, PhD, will discuss how Asimov's LV Edge Producer and Packaging Systems are leading to higher-quality, higher-productivity cell lines to support clinical ...

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...

Genenta Science S.p.A. stock surged after ANEMOCYTE partnership. Discover temferon's cancer trial updates and what’s next.

OXB to participate in upcoming investor conferences and events Oxford, UK – 27 October 2025: OXB (LSE: OXB), a global quality and innovation-led ...

Growing use of CAR-T therapy for large B-cell lymphoma, gene delivery innovations to solid lesions, and growing investor interest are driving the cancer gene therapy industry forwardAustin, Oct. 23, ...

Evidence is emerging that promoter choice may be a relevant factor in insertional oncogenesis, despite the overall safety profile of self-inactivating lentiviral vectors themselves. 22 In a recent ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. JW (Cayman) Therapeutics Co. Ltd. ( ...

Less than two months after OXB revealed an equity raise of 60 million pounds sterling ($81 million) as part a plan to expand its operations in the U.S., the U.K.-based cell and gene therapy ...

Physics and Python stuff. Most of the videos here are either adapted from class lectures or solving physics problems. I really like to use numerical calculations without all the fancy programming ...